Oops! It appears that you have disabled your Javascript. In order for you to see this page as it is meant to appear, we ask that you please re-enable your Javascript!
DRL in R&D pact with Purdue Universit...
Home  »  Community News  »  DRL in R&D pact with...
DRL in R&D pact with Purdue University
Pharma News

US-based Purdue University on Wednesday announced that it has entered into a Memorandum of Understanding (MoU) with homegrown pharma giant Dr Reddy’s Laboratories (DRL) to forge a `strong strategic partnership’ in a range of research areas and novel technologies.

Suresh Garimella, Purdue executive vice-president (research and partnerships), and Amit Biswas, executive vicepresident and global head of integrated product development, DRL, had signed an MoU on June 22.

“Purdue has tremendous strength in pharmaceutical drug discovery and development research, but we need additional partners to help translate our discoveries through to the delivery of a medicine or technology . DRL is a global pharmaceutical company that shares our mission to accelerate the rate at which new, advanced treatments make it to the millions of patients in need of relief.This partnership combines strengths that could lead to world-changing research,“ Garimella said.

According to the university, the partnership will focus on research in pharmaceutical processes and product development. “Areas of planned collaborative research and education include targeted drug delivery , manufacturing technology , scale-up of pharmaceutical operations, process engineering, and research and development methodologies and technology ,“ it added.The university also pointed out that the collaboration will also include student engagement and faculty exchanges and may include a site at Purdue Research Park.

“The long-term research partnership augurs well for DRL’s philosophy of providing access to innovative, highquality medicines to global patients at affordable costs.Purdue University has talented researchers, unique instrumentation and an interdisciplinary approach to solving technology challenges that make them a perfect partner as we sharpen our focus on innovative drug development programs. Together, we can find innovative solutions to address unmet needs and improve the health of people all over the world,“ Biswas of DRL added.

Leave a reply

You must be logged in to post a comment.